SEPTIN9 and colorectal cancer: In colorectal cancer, methylated SEPT9 (mSEPT9) can be used as a tumor biomarker to diagnose the disease and predict the risk of prognosis, recurrence, and metastasis, and its value has been confirmed in clinical practice [10].